Lawmakers Float Idea to Allow Drugs in Shortage From Troubled Drugmakers

Generic Line
Drugmakers may soon be able to get critical shortage drugs to market faster with a proposed shortcut for proving manufacturing compliance that’s included in draft legislation to reauthorize the FDA’s user fee programs.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00